scai Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

Plan for the year ahead by registering for SCAI 2020 Scientific Sessions. World-renowned experts will share...

source: SCAI

Submit late-breaking clinical science, follow-up data from major randomized trials, single or multi-center registries, and first-in-man experiences with novel devices or drugs for the opportunity to present at SCAI 2020. Submission deadline is March 4.

source: SCAI

A paclitaxel-coated balloon was not associated with elevated mortality risk in patients who underwent revascularization for critical limb ischemia, according to five-year data from the IN.PACT DEEP trial. As Healio previously reported,...

source: Healio

For the small proportion of TAVR patients at high risk of coronary obstruction, a new registry study confirms that preventive stent implantation across the coronary ostia is safe, with good survival and low rates of stent thrombosis...

source: TCTMD

The use of intravascular lithotripsy (IVL) for the treatment of moderately to severely calcified peripheral arterial disease (PAD) lesions was found to be a safe and effective therapeutic option, according to study results...

source: The Cardiology Advisor

Transradial access for percutaneous coronary intervention (PCI) in the U.S. has rapidly grown over the past 20 years, from zero percent to between 40-50 percent of PCI cases. Clinical studies have continued to support the usage of radial access as a way to reduce vascular...

source: Diagnostic and Interventional Cardiology


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to SCAI This Week

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SCAI? Yes   No
Privacy Policy